Delivery Order SPE2DR25D6028-SPE2DR26FASJF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,677.12 to AmerisourceBergen Drug Corp for the supply of Briviact 100 mg tablets (60-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitive, non-set-aside award employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Briviact 50 mg tablets (60-count packages) with a ceiling value of $1,868.82. This competitively awarded, firm fixed-price delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,857.36 to AmerisourceBergen Drug Corp for Briviact 100 mg tablets (60-count) on November 5, 2025, with completion scheduled for November 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of pharmaceutical supply under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,072.23 for Briviact 100 mg tablets (60-count) with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and reflects AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical procurement system. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $9,077.52 to AmerisourceBergen Drug Corp for Briviact 50 mg tablets (60-count supply) on December 9, 2025, with an ultimate completion date of December 10, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order under its substantial Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,320.35 to AmerisourceBergen Drug Corp for Briviact 50 mg tablets (60-count supply) on September 26, 2025, with an ultimate completion date of September 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Briviact 100 mg tablets (60-count) valued at $2,513.19 on November 10, 2025, with completion scheduled for November 12, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical vendor,...
- The Defense Logistics Agency awarded a delivery order valued at $5,136.01 to AmerisourceBergen Drug Corp for the supply of Briviact 50 mg tablets (60-count packaging) with a completion date of July 30, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical products will be delivered to the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $3,869.09 to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Briviact 50 mg tablets (60-count). This competitively awarded, firm fixed-price contract requires delivery by November 18, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a child order under AmerisourceBergen's larger contract vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $2,004.05 to AmerisourceBergen Drug Corp for Briviact 50 mg tablets (60-count units) on November 18, 2025, with completion expected by November 19, 2025. This firm fixed-price, non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FASJFDelivery Order
The Defense Logistics Agency awarded a $5,394.54 delivery order to AmerisourceBergen Drug Corp for Briviact 100mg tablets (60 count) on December 4, 2025, with completion expected by December 5, 2025. This non-competitive, firm fixed-price delivery order represents a single pharmaceutical product shipment to support federal medical supply needs. The award was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving the federal healthcare system. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent contract serves as a comprehensive pharmaceutical prime vendor vehicle supporting the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems with a broad range of medications, vaccines, and medical supplies across multiple therapeutic domains. AmerisourceBergen's federal contracting portfolio demonstrates its capability to fulfill diverse medical procurement requirements through competitive processes, with this particular order reflecting routine pharmaceutical supply deliveries essential to military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 12/3/25 |